Related Experiment Video
Updated: Jul 14, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Anti-Atherosclerosis and Anti-Hyperlipidemia Functions of Terminalia catappa Fruit
Doris Tabansi1, Daniel Dahiru1, Ambrose Teru Patrick2,3
1Department of Biochemistry, Faculty of Life Sciences, Modibbo Adama University of Technology, Yola 640101, Nigeria.
Insights
Terminalia catappa fruit extracts show promise in reversing harmful lipid profiles in rats with diet-induced atherosclerosis. This natural approach may offer a safer alternative to synthetic drugs for treating atherosclerosis.
Area of Science:
- Pharmacology and Toxicology
- Natural Product Chemistry
- Cardiovascular Research
Background:
- Atherosclerosis is a silent, progressive disease driven by factors like diet, hyperlipidemia, and aging.
- Current synthetic treatments for atherosclerosis carry significant risks, including myositis and renal failure.
- Research is exploring natural compounds as safer alternatives for managing atherosclerosis.
Purpose of the Study:
- To investigate the antiatherosclerotic and antihyperlipidemic potential of Terminalia catappa fruit extracts.
- To test the hypothesis using a diet-induced atherosclerosis rat model.
Main Methods:
- Wistar rats were induced with atherosclerosis using an atherogenic diet.
- Phytochemical analysis of Terminalia catappa extracts was performed.
- Key lipid profile markers (TC, TG, HDL) and liver/cardiac enzymes (AST, ALT, CK, LDH) were quantified.
Main Results:
- Terminalia catappa extracts contained various bioactive compounds, including flavonoids, saponins, and phenols.
- Atherogenic diet significantly increased lipid levels (TC, TG, LDL, VLDL) in rats.
- Treatment with T. catappa extracts reversed the atherogenic lipid profile, reducing coronary risk and atherogenic indices while increasing the cardioprotective index.
Conclusions:
- Terminalia catappa fruit extracts demonstrate significant antihyperlipidemic and antiatherosclerotic effects in a rat model.
- The findings suggest that Terminalia catappa contains bioactive molecules with therapeutic potential for atherosclerosis treatment.
Abstract:
Background: Atherosclerosis is a chronic pathological condition that has remained clinically silent for decades, and the epidemic has continued to be on the rise due to risk factors, including diet, lifestyle, hyperlipidemia, pathogenic microorganisms, and aging. Using various synthetic drugs in treating atherosclerosis is associated with a high risk of myositis, angioedema, myoglobinuria, and acute renal failure. Various side effects of the available drugs have been reported; attempts are underway to explore natural sources with antiatherosclerotic activity. Aim and objective: Using a diet-induced atherosclerosis rat model, the current study tested the hypothesis of antiatherosclerotic and antihyperlipidemic roles of Terminalia catappa fruit extracts. Materials and Methods: Atherosclerosis in Wistar rats was induced using an atherogenic diet. Total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (AP), creatine kinase (CK), and lactate dehydrogenase (LDH) were determined using analytical kits. Results: Quantitative phytochemical analysis of the extracts demonstrated that the plant had flavonoids, saponins, tannins, terpenoids, alkaloids, cardiac glycosides, sterols, phenols, and anthraquinones. Diet-induced atherogenic Wistar rats showed a significant (p < 0.05) increase in total cholesterol, triglyceride, low-density lipoprotein cholesterol, and very low-density lipoprotein cholesterol compared to the healthy control group; however, the atherogenic lipid profile was reversed by the treatment of T. catappa fruit extracts. The biochemical experiments demonstrate that T. catappa fruit extracts have an antihyperlipidaemic effect, shown by a decreased coronary risk index and the atherogenic index, and an increased cardioprotective index, compared to disease control. Conclusion: The current study indicates that T. catappa fruit extracts may contain bioactive molecules to treat atherosclerosis.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis I: Introduction

